14-day Premium Trial Subscription Try For FreeTry Free
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Price (Quote)

New York Stock Exchange
Open Broker Account
$0.130
+0 (+0%)
At Close: Jan 16, 2018
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 16th Jan 2018 MSTX stock ended at $0.130. During the day the stock fluctuated 0% from a day low at $0.130 to a day high of $0.130.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Mast Therapeutics, Inc prices

Date Open High Low Close Volume
Oct 28, 2016 $0.0800 $0.0800 $0.0800 $0.0800 2 783 900
Oct 27, 2016 $0.0800 $0.0800 $0.0800 $0.0800 2 599 000
Oct 26, 2016 $0.0800 $0.0800 $0.0800 $0.0800 3 980 900
Oct 25, 2016 $0.0900 $0.0900 $0.0800 $0.0800 4 505 800
Oct 24, 2016 $0.0900 $0.0900 $0.0800 $0.0800 4 468 200
Oct 21, 2016 $0.0900 $0.0900 $0.0900 $0.0900 3 796 900
Oct 20, 2016 $0.0900 $0.0900 $0.0900 $0.0900 4 158 200
Oct 19, 2016 $0.0900 $0.100 $0.0800 $0.0900 8 433 500
Oct 18, 2016 $0.0900 $0.0900 $0.0800 $0.0800 7 097 200
Oct 17, 2016 $0.100 $0.100 $0.0800 $0.0900 11 429 100
Oct 14, 2016 $0.0900 $0.0900 $0.0800 $0.0800 8 566 800
Oct 13, 2016 $0.0900 $0.0900 $0.0800 $0.0900 10 995 600
Oct 12, 2016 $0.0900 $0.0900 $0.0900 $0.0900 4 169 500
Oct 11, 2016 $0.100 $0.100 $0.0900 $0.100 3 392 900
Oct 10, 2016 $0.100 $0.100 $0.0900 $0.100 3 368 600
Oct 07, 2016 $0.100 $0.100 $0.0900 $0.100 7 050 000
Oct 06, 2016 $0.110 $0.110 $0.100 $0.100 5 929 500
Oct 05, 2016 $0.100 $0.100 $0.100 $0.100 7 166 500
Oct 04, 2016 $0.110 $0.110 $0.100 $0.100 8 353 700
Oct 03, 2016 $0.110 $0.110 $0.100 $0.110 7 623 300
Sep 30, 2016 $0.100 $0.110 $0.0900 $0.110 19 142 300
Sep 29, 2016 $0.110 $0.110 $0.100 $0.100 14 048 300
Sep 28, 2016 $0.120 $0.120 $0.100 $0.110 12 957 800
Sep 27, 2016 $0.130 $0.130 $0.110 $0.110 16 193 100
Sep 26, 2016 $0.130 $0.140 $0.120 $0.120 24 895 300
Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Golden Star

Ticker Date Change Price
VCSH May 03 0.0130% $76.93
BNDX May 03 0.349% $48.68
BBCA May 03 1.26% $65.44
ISTB May 03 0.0425% $47.11
ADTH May 03 5.56% $3.24
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT